These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 24852483

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pattern of frequent but nontargeted pharmacologic thromboprophylaxis for hospitalized patients with cancer at academic medical centers: a prospective, cross-sectional, multicenter study.
    Zwicker JI, Rojan A, Campigotto F, Rehman N, Funches R, Connolly G, Webster J, Aggarwal A, Mobarek D, Faselis C, Neuberg D, Rickles FR, Wun T, Streiff MB, Khorana AA.
    J Clin Oncol; 2014 Jun 10; 32(17):1792-6. PubMed ID: 24799475
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
    Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA, ENDORSE Investigators.
    Thromb Haemost; 2010 Apr 10; 103(4):736-48. PubMed ID: 20135072
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Venous thromboembolism prophylaxis in emergency department admissions.
    Levine RL, Hergenroeder GW, Miller CC, Davies A.
    J Hosp Med; 2007 Mar 10; 2(2):79-85. PubMed ID: 17427248
    [Abstract] [Full Text] [Related]

  • 29. [Thromboembolic prophylaxis in hospitalized medical patients].
    Braekkan S, Grimsgaard S, Hansen JB.
    Tidsskr Nor Laegeforen; 2007 May 03; 127(9):1177-80. PubMed ID: 17479133
    [Abstract] [Full Text] [Related]

  • 30. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM, Pendleton R, Skordos L, Wheeler M, Rodgers GM.
    Am J Hematol; 2005 Mar 03; 78(3):167-72. PubMed ID: 15726600
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The under use of thromboprophylaxis in older medical in-patients: a regional audit.
    South A, Iveson E, Allgar V, Harbison J, Geriatrics Registrars Research and Audit Network Yorkshire.
    QJM; 2007 Nov 03; 100(11):685-9. PubMed ID: 17938143
    [Abstract] [Full Text] [Related]

  • 33. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
    Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG.
    Thromb Haemost; 2005 Oct 03; 94(4):750-9. PubMed ID: 16270626
    [Abstract] [Full Text] [Related]

  • 34. Inappropriate prescription of low molecular weight heparins for thromboprophylaxis among older hospitalized patients.
    Garasto S, Fusco S, Onder G, Sganga F, Mammarella F, Volpato S, Ruggiero C, Abbatecola AM, Lattanzio F, Corsonello A.
    Aging Clin Exp Res; 2017 Jun 03; 29(3):483-490. PubMed ID: 27114077
    [Abstract] [Full Text] [Related]

  • 35. Antibiotic prescribing in primary care by international medical graduates and graduates from Swedish medical schools.
    Neumark T, Brudin L, Mölstad S.
    Fam Pract; 2015 Jun 03; 32(3):343-7. PubMed ID: 25715961
    [Abstract] [Full Text] [Related]

  • 36. [Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].
    Losonczy H, Tar A, ENDORSE magyar vizsgálói.
    Orv Hetil; 2008 Nov 02; 149(44):2069-76. PubMed ID: 18952526
    [Abstract] [Full Text] [Related]

  • 37. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM, Kolansky DM, Spinler SA.
    Pharmacotherapy; 2006 Aug 02; 26(8):1086-90. PubMed ID: 16863485
    [Abstract] [Full Text] [Related]

  • 38. Assessment of venous thromboembolism risk and adequacy of prophylaxis in selected acute care medical centres in Arabian Gulf States: results from the ENDORSE study.
    Alsayegh F, Kamaliddin H, Sheshah E, Bukhamseen N, Alkhuwaitir T, Elhoufi A.
    Med Princ Pract; 2012 Aug 02; 21(6):522-8. PubMed ID: 22688685
    [Abstract] [Full Text] [Related]

  • 39. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital.
    Akhloufi H, Streefkerk RH, Melles DC, de Steenwinkel JE, Schurink CA, Verkooijen RP, van der Hoeven CP, Verbon A.
    Eur J Clin Microbiol Infect Dis; 2015 Aug 02; 34(8):1631-7. PubMed ID: 26017664
    [Abstract] [Full Text] [Related]

  • 40. Venous thromboembolism prophylaxis-prescribing patterns among elderly medical patients in a Saudi tertiary care center: success or failure?
    Alabdulkarim DA, Almohammed OA, Al AMA, Almaklafi NS, Alkathiri MA, Aljohani MA.
    J Geriatr Cardiol; 2020 Dec 28; 17(12):775-781. PubMed ID: 33424945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.